The Therapeutic Implications of Intratumoral Regulatory T Cells
Open Access
- 1 December 2005
- journal article
- editorial
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (23) , 8226-8229
- https://doi.org/10.1158/1078-0432.ccr-05-2035
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Toll-Like Receptor 8-Mediated Reversal of CD4 + Regulatory T Cell FunctionScience, 2005
- Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymusNature, 2005
- Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumorsThe Journal of Experimental Medicine, 2005
- Smoldering and polarized inflammation in the initiation and promotion of malignant diseaseCancer Cell, 2005
- CTLA-4 Blockade: Unveiling Immune RegulationJournal of Clinical Oncology, 2005
- Interferon-γ expression is an independent prognostic factor in ovarian cancerAmerican Journal of Obstetrics and Gynecology, 2004
- In Vivo Instruction of Suppressor Commitment in Naive T CellsThe Journal of Experimental Medicine, 2004
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004
- CTLA-4-Mediated Inhibition in Regulation of T Cell Responses: Mechanisms and Manipulation in Tumor ImmunotherapyAnnual Review of Immunology, 2001
- Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.The Journal of Experimental Medicine, 1988